In this study, MSH6 mutation carriers presented later with CRC and EC than those with MLH1 or MSH2 mutations, consistent with previous studies. Furthermore, women with truncating MLH1 mutations presented with EC on average 6 years later than those with nontruncating mutations, which to our knowledge has not been reported before. This evidence concerns the gene MLH1 and colorectal carcinoma.